# Micafungin Versus Fluconazole for Prevention of Invasive Fungal Disease in Living Donor Liver Transplant Recipients

> **NCT01974375** · PHASE3 · UNKNOWN · sponsor: **Asan Medical Center** · enrollment: 172 (estimated)

## Conditions studied

- Liver Transplant Recipient

## Interventions

- **DRUG:** micafungin
- **DRUG:** Fluconazole

## Key facts

- **NCT ID:** NCT01974375
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-08
- **Primary completion:** 2014-06
- **Final completion:** 2014-12
- **Target enrollment:** 172 (ESTIMATED)
- **Last updated:** 2013-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01974375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01974375, "Micafungin Versus Fluconazole for Prevention of Invasive Fungal Disease in Living Donor Liver Transplant Recipients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01974375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*